- Sunday, November 9, 2025
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Digital Respiratory Devices Market by Product Type (Therapeutic Devices (Inhalers, (Smart Inhalers and Adaptors for Conventional Inhalers) and Nebulizers), Diagnostic Devices (Spirometers, Asthma Monitors, and Others) and Apps), By Application (Asthma, COPD and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa)
Global Digital Respiratory Devices Market Overview:
Global Digital Respiratory Devices Market is estimated to reach USD 307.2 billion by 2030, growing at a CAGR of 29.1% during the forecast period of 2022-2030. It was valued at USD 41.9 billion in 2022. Digital Respiratory Devices used compromises therapeutic and diagnostic devices that are connected to smartphone applications or other data collection modules. These devices used to data include approaches to monitoring and improving adherence, such as electronic inhalers, text messaging and reminders, and self-management tools include web-based and mobile applications to record symptoms and monitor lung function. Smart inhalers are developed such that it wirelessly sends data on inhaler usage directly to a mobile health platform website. Digital respiratory devices also assist in visualization of measurements and integration into a wider dataset, such that it contains in a patient’s electronic medical records. It can monitor through Bluetooth-connected devices and mobile applications that measure peak flow, exhaled nitric oxide fraction (FeNO), physical activity, and ambient pollution. These devices used to monitor the treatment and monitoring of asthma, chronic obstructive pulmonary diseases (COPD), and other respiratory diseases.Global Digital Respiratory Devices Market Insights
The growing prevalence of respiratory diseases coupled with the rapid technological advancements in the healthcare industry is key factors expected to drive the growth of the global digital respiratory devices market in the next few years. Moreover, the rising awareness among individuals regarding the benefits of connected inhalers along with the growing adoption of sensor technologies and apps by doctors to monitor and manage inhalation of medications will augment the growth of the global digital respiratory devices industry. Furthermore, recent outbreak pandemic COVID-19 has worsened across the world, and the epidemic situation in the United States is difficult, with more than 100,000 confirmed cases recorded, for which there is the demand for 140,000 beds, 40,000 ICU beds and a minimum of 30,000 respirators. Also, the growing demand for enhanced portable and compact respiratory care devices, multimodal ventilation, coupled with the rising adoption of non-invasive ventilation, are estimated to trigger the global respiratory devices market size. Further, the upsurge in demand for software to measure and improve outcomes for respiratory diseases will spur the robust growth of the digital respiratory devices industry worldwide. According to WHO, respiratory diseases like Chronic Obstructive Pulmonary disorder will become the third leading cause of death worldwide by 2030. This surge in demand for digital respiratory devices in the future periods.Growth Driver
Huge demand for digital respiratory devices for pandemic COVID-19 across the world
Recently, pneumonia of a new type of coronavirus infection, COVID-19, occurred in Wuhan, Hubei, and other regions. To date, there 1,214, 466 confirmed cases with 67,767 deaths in 211 countries. With the continued spread of this virus, which can cause pneumonia and difficulty breathing, hospitals are facing a limited supply of ventilators. The COVID-19 virus targets the lungs and may cause complications such as pneumonia and acute respiratory distress syndrome. Today, governments worldwide are playing catch-up, swiftly intervening in an attempt to create alliances with manufacturers to handle the COVID-19 threat. For example, recently, New York Governor Andrew Cuomo demand for least 30,000 respirators to ensure proper care of patients. In fact, the United States also has a small amount of respiratory equipment stored in hospital warehouses. In response to the spread of the virus, US President Trump has invoked the Defense Production Act. The bill allows the federal government to force private companies to produce breathing equipment and other necessities in emergencies.The rise in the prevalence of respiratory diseases
According to WHO, Asthma is the most common chronic disease among children worldwide and stated that around 235 million people were living with asthma in 2019. Also, WHO reports that the prevalence of 251 million cases of COPD globally in 2016 and the primary cause of COPD is exposure to tobacco smoke. WHO estimates that in 2016, some 58% of outdoor air pollution-related premature deaths were due to ischaemic heart disease and stroke.Product Type Segmental Analysis
Based on product type, the global digital respiratory devices market classified into Therapeutic Devices (Inhalers, (Smart Inhalers and Adaptors for Conventional Inhalers) and Nebulizers), Diagnostic Devices (Spirometers, Asthma Monitors, and Others) and Apps). The Therapeutic Devices segmented held for maximum revenue share in 2021 and predicted to gain a major share in the digital respiratory devices market by 2030. It is owing to the presence of sensors attached inhalers, which stores data were measuring the number of dosages and surge the efficiency of the drug. Additionally, smart inhalers help adoption in the proper management of COPD and asthma. It includes Inhalers such as Smart Inhalers and Adaptors for Conventional Inhalers and Nebulizers. The diagnostic devices segment will drive with a significant rate in the forecast period. It is attributable to its use to diagnose asthma, chronic obstructive pulmonary disease (COPD), and other conditions with mobile connectivity. Furthermore, it assists in respiratory monitoring in clinical trials.Application Segmental Analysis
Based on the application, the global digital respiratory devices market classified into Asthma, COPD, and Others. The Asthma segment accounted for a higher market share in 2021 and estimated to generate the largest revenue share by 2030. It is due to the high prevalence of asthma patients around the world, coupled with technological advancements in respiratory devices such as it provides accurate asthma monitoring within the home and medical environment. The COPD segment will be the fastest-growing segment in the forecast periods on account of the growing prevalence of chronic pulmonary and respiratory diseases in developed as well as developing countries.Distribution Channel Segmental Analysis
Based on Distribution Channel, the global digital respiratory devices market segregated into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Hospital Pharmacies segment expected to gain maximum revenue by 2030 owing to the financial capabilities of hospitals to purchase high-priced instruments coupled with the easy availability of digital respiratory devices at hospital pharmacies. The Retail Pharmacies segment will be the fastest-growing segment during the analysis period on account of the rise in the number of pharmacy stores in developing countries coupled with the surge in awareness among people about the benefits of digital respiratory devices.Region Segmental Analysis
Based on geography, the global digital respiratory devices market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America estimated to occupy the lion’s market share by 2030, owing to the presence of keys players in these regions coupled with a higher adoption rate of digital medical devices and upsurge in per capita income of individuals in these regions. Europe will grow with a lucrative rate during the forecast period due to the high prevalence of respiratory diseases coupled with the presence of a highly developed healthcare system.Competitor Analysis
Companies such as Teva Pharmaceutical Industries Ltd., Propeller Health, 3M, AstraZeneca, Glenmark, Adherium Ltd., Pneuma Respiratory, Findair Sp. Z o. o, Cohero Health, Inc., Amiko Digital Health Limited, Boehringer Ingelheim International GmbH, Capsule Technologies, GlaxoSmithKline PLC, Novartis AG, Propeller Health, and Sensiron AG are the key players in the Global Digital Respiratory Devices Market.Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global Digital Respiratory Devices manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to digital respiratory devices
- Regulatory bodies
- Suppliers
- Retailers
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Product Type- Therapeutic Devices
- Inhalers,
- Smart Inhalers
- Adaptors for Conventional Inhalers
- Nebulizers
- Inhalers,
- Diagnostic Devices
- Spirometers
- Asthma Monitors
- Others
- Apps
- Asthma
- COPD
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Europe Spare Parts Logistics in Night Market
Live Cell Encapsulation Market
Infectious Disease Rapid Diagnostics Testing Market
Industrial Marking and Labelling System Market
Global Passenger Information System Market
Report Content
- Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
- Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
- Executive Summary
- Market Insights
4.1. Supply Chain Analysis
4.2. Economic Factor Analysis
4.2.1. Drivers
4.2.2. Trends
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Competitors & Product Analysis
4.5. Regulatory Framework
4.6. Company market share analysis, 2022
4.7. Porter’s Five forces analysis
4.8. Price point analysis
4.9. New Investment Analysis
4.10. PESTEL Analysis
- Global Digital Respiratory Devices Market Overview
5.1. Market Size & Forecast,2017-2030
5.1.1. Demand
5.1.1.1. By Value (USD Billion)
5.2. Market Share & Forecast, 2017-2030
5.2.1. By Product Type
5.2.1.1. Therapeutic Devices
5.2.1.1. Inhalers
5.2.1.1.1. Smart Inhalers
5.2.1.1.2. Adaptors for Conventional Inhalers
5.2.1.2. Nebulizers
5.2.1.2. Diagnostic Devices
5.2.1.2.1. Spirometers
5.2.1.2.2. Asthma Monitors
5.2.1.2.3. Others
5.2.1.3. Apps
5.2.2. By Application
5.2.2.1. Asthma
5.2.2.2. COPD
5.2.2.3. Others
5.2.3. By Distribution Channel
5.2.3.1. Hospital Pharmacies
5.2.3.2. Retail Pharmacies
5.2.3.3. Online Pharmacies
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. Asia-Pacific
5.2.4.4. South America
5.2.4.5. The Middle East & Africa
- North America Digital Respiratory Devices Market Overview
6.1. North America Digital Respiratory Devices Market Size & Forecast,2017-2030
6.1.1. Demand
6.1.1.1. By Value (USD Billion)
6.2. Market Share & Forecast, 2017-2030
6.2.1. By Product Type
6.2.1.1. Therapeutic Devices
5.2.1.3. Inhalers
5.2.1.3.1. Smart Inhalers
5.2.1.3.2. Adaptors for Conventional Inhalers
5.2.1.4. Nebulizers
6.2.1.2. Diagnostic Devices
6.2.1.2.1. Spirometers
6.2.1.2.2. Asthma Monitors
6.2.1.2.3. Others
6.2.1.3. Apps
6.2.2. By Application
6.2.2.1. Asthma
6.2.2.2. COPD
6.2.2.3. Others
6.2.3. By Distribution Channel
6.2.3.1. Hospital Pharmacies
6.2.3.2. Retail Pharmacies
6.2.3.3. Online Pharmacies
6.2.4. By Country
6.2.4.1. US
6.2.4.2. Canada
6.2.4.3. Mexico
6.2.5. Company Market Share (Top 3-5)
6.2.6. Economic Impact Study on North America Digital Respiratory Devices Market
- Europe Digital Respiratory Devices Market Overview
7.1. Europe Digital Respiratory Devices Market Size & Forecast,2017-2030
7.1.1. Demand
7.1.1.1. By Value (USD Billion)
7.2. Market Share & Forecast, 2017-2030
7.2.1. By Product Type
7.2.1.1. Therapeutic Devices
5.2.1.5. Inhalers
5.2.1.5.1. Smart Inhalers
5.2.1.5.2. Adaptors for Conventional Inhalers
5.2.1.6. Nebulizers
7.2.1.2. Diagnostic Devices
7.2.1.2.1. Spirometers
7.2.1.2.2. Asthma Monitors
7.2.1.2.3. Others
7.2.1.3. Apps
7.2.2. By Application
7.2.2.1. Asthma
7.2.2.2. COPD
7.2.2.3. Others
7.2.3. By Distribution Channel
7.2.3.1. Hospital Pharmacies
7.2.3.2. Retail Pharmacies
7.2.3.3. Online Pharmacies
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. UK
7.2.4.3. France
7.2.4.4. Italy
7.2.4.5. Rest of Europe
7.2.5. Company Market Share (Top 3-5)
7.2.6. Economic Impact Study on Europe Digital Respiratory Devices Market
- Asia-Pacific Digital Respiratory Devices Market Overview
8.1. Asia-Pacific Digital Respiratory Devices Market Size & Forecast,2017-2030
8.1.1. Demand
8.1.1.1. By Value (USD Billion)
8.2. Market Share & Forecast, 2017-2030
8.2.1. By Product Type
8.2.1.1. Therapeutic Devices
5.2.1.7. Inhalers
5.2.1.7.1. Smart Inhalers
5.2.1.7.2. Adaptors for Conventional Inhalers
5.2.1.8. Nebulizers
8.2.1.2. Diagnostic Devices
8.2.1.2.1. Spirometers
8.2.1.2.2. Asthma Monitors
8.2.1.2.3. Others
8.2.1.3. Apps
8.2.2. By Application
8.2.2.1. Asthma
8.2.2.2. COPD
8.2.2.3. Others
8.2.3. By Distribution Channel
8.2.3.1. Hospital Pharmacies
8.2.3.2. Retail Pharmacies
8.2.3.3. Online Pharmacies
8.2.4. By Country
8.2.4.1. India
8.2.4.2. Japan
8.2.4.3. Australia
8.2.4.4. Rest of Asia Pacific
8.2.5. Company Market Share (Top 3-5)
8.2.6. Economic Impact Study on Asia Pacific Digital Respiratory Devices Market
- South America Digital Respiratory Devices Market Overview
9.1. South America Digital Respiratory Devices Market Size & Forecast,2017-2030
9.1.1. Demand
9.1.1.1. By Value (USD Billion)
9.2. Market Share & Forecast, 2017-2030
9.2.1. By Product Type
9.2.1.1. Therapeutic Devices
5.2.1.9. Inhalers
5.2.1.9.1. Smart Inhalers
5.2.1.9.2. Adaptors for Conventional Inhalers
5.2.1.10. Nebulizers
9.2.1.2. Diagnostic Devices
9.2.1.2.1. Spirometers
9.2.1.2.2. Asthma Monitors
9.2.1.2.3. Others
9.2.1.3. Apps
9.2.2. By Application
9.2.2.1. Asthma
9.2.2.2. COPD
9.2.2.3. Others
9.2.3. By Distribution Channel
9.2.3.1. Hospital Pharmacies
9.2.3.2. Retail Pharmacies
9.2.3.3. Online Pharmacies
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Argentina
9.2.4.3. Rest of South America
9.2.5. Company Market Share (Top 3-5)
9.2.6. Economic Impact Study on South America Digital Respiratory Devices Market
- The Middle East & Africa Digital Respiratory Devices Market Overview
10.1. The Middle East & Africa Digital Respiratory Devices Market Size & Forecast,2017-2030
10.1.1. Demand
10.1.1.1. By Value (USD Billion)
10.2. Market Share & Forecast, 2017-2030
10.2.1. By Product Type
10.2.1.1. Therapeutic Devices
5.2.1.11. Inhalers
5.2.1.11.1. Smart Inhalers
5.2.1.11.2. Adaptors for Conventional Inhalers
5.2.1.12. Nebulizers
10.2.1.2. Diagnostic Devices
10.2.1.2.1. Spirometers
10.2.1.2.2. Asthma Monitors
10.2.1.2.3. Others
10.2.1.3. Apps
10.2.2. By Application
10.2.2.1. Asthma
10.2.2.2. COPD
10.2.2.3. Others
10.2.3. By Distribution Channel
10.2.3.1. Hospital Pharmacies
10.2.3.2. Retail Pharmacies
10.2.3.3. Online Pharmacies
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Rest of the Middle East & Africa
10.2.5. Company Market Share (Top 3-5)
10.2.6. Economic Impact Study on Middle East & Africa Digital Respiratory Devices Market
- Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. Teva Pharmaceutical Industries Ltd.
11.7.2. Propeller Health
11.7.3. 3M, AstraZeneca
11.7.4. Glenmark
11.7.5. Adherium Ltd.
11.7.6. Pneuma Respiratory
11.7.7. Findair Sp. z o. o
11.7.8. Cohero Health, Inc.
11.7.9. Amiko Digital Health Limited
11.7.10. Boehringer Ingelheim International GmbH
11.7.11. Capsule Technologies
11.7.12. GlaxoSmithKline PLC
11.7.13. Novartis AG
11.7.14. Propeller Health
11.7.15. Sensiron AG
11.7.16. Other Prominent Players
Frequently Asked Questions (FAQ)
Global Digital Respiratory Devices Market is estimated to reach USD 307.2 billion by 2030, growing at a CAGR of 29.1% during the forecast period of 2022-2030. It was valued at USD 41.9 billion in 2022.
The growing prevalence of respiratory diseases coupled with the rapid technological advancements in the healthcare industry is key factors expected to drive the growth of the global digital respiratory devices market.
Companies such as Teva Pharmaceutical Industries Ltd., Propeller Health, 3M, AstraZeneca, Glenmark, Adherium Ltd., Pneuma Respiratory, Findair Sp. Z o. o, Cohero Health, Inc., Amiko Digital Health Limited, Boehringer Ingelheim International GmbH, Capsule Technologies, GlaxoSmithKline PLC, Novartis AG, Propeller Health, and Sensiron AG are the key players in the Global Digital Respiratory Devices Market.
North America estimated to occupy the lion’s market share by 2030.
